(ISSN 2577-5790)
OBM Genetics is an international Open Access journal published quarterly online by LIDSEN Publishing Inc. It accepts papers addressing basic and medical aspects of genetics and epigenetics and also ethical, legal and social issues. Coverage includes clinical, developmental, diagnostic, evolutionary, genomic, mitochondrial, molecular, oncological, population and reproductive aspects. It publishes a variety of article types (Original Research, Review, Communication, Opinion, Comment, Conference Report, Technical Note, Book Review, etc.). There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.
Publication Speed (median values for papers published in 2024): Submission to First Decision: 6.4 weeks; Submission to Acceptance: 12.2 weeks; Acceptance to Publication: 7 days (1-2 days of FREE language polishing included)
Special Issue
Genetics in Surgical Practice: Advances in Hereditary and Endocrine Disorders
Submission Deadline: May 31, 2026 (Open) Submit Now
Guest Editor
Eugenia Yiannakopoulou, MD, PhD
Department of Biomedical Sciences, Faculty of Health Sciences, University of West Attica, Athens, Greece
Research Interests: Pharmacogenomics and drug safety; nonsteroidal anti-inflammatory agents; prooxidants-antioxidants; systematic review-meta-analysis; breast cancer endocrine treatment; breast cancer targeted therapy; breast cancer chemoprophylaxis
About This Topic
Genetics plays a significant role in clinical practice, enabling the estimation of the risk of hereditary disease as well as guiding the prevention, the treatment and follow up. Novel technologies such as next generation sequencing that allow the sequencing of the whole human genome in 24 h, at affordable cost, render feasible the application of genetic and genomic information in surgical practice. Importantly, genetics plays a crucial role in surgical decision in the context of hereditary and endocrine disorders. Genetic testing is mandatory for phaechromocytoma as the diagnosis of hereditary phaeochromocytoma affects surgical decision on the extent of surgery and follow up. Especially genetic testing has revolutionized the surgical treatment of hereditary colorectal, breast and thyroid cancer. However, many open questions still exist and more knowledge is needed for fully integrating genomic information in the surgical practice.
Keywords
MEN I; MEN II; pheoachrmocytomema; hereditary colorectal cancer; hereditary breast cancer; hereditary thyroid cancer; hereditary pancreatic cancer; Lynch Syndrome
Manuscript Submission Information
Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (genetics@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.
Welcome your submission!
2023 | ![]() |
|
CiteScore | SJR | SNIP |
0.4 | 0.160 | 0.093 |